71 related articles for article (PubMed ID: 17356228)
1. Role of dihydroxyvitamin D(3) and its nuclear receptor in novel directed therapies for cancer.
Ondková S; Macejová D; Brtko J
Gen Physiol Biophys; 2006 Dec; 25(4):339-53. PubMed ID: 17356228
[TBL] [Abstract][Full Text] [Related]
2. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
Nezbedova P; Brtko J
Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of the intracellular activities of thyroid gland hormones].
Brtko J
Vnitr Lek; 2006 Oct; 52(10):935-40. PubMed ID: 17063806
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and cancer.
Spina CS; Tangpricha V; Uskokovic M; Adorinic L; Maehr H; Holick MF
Anticancer Res; 2006; 26(4A):2515-24. PubMed ID: 16886659
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M; Makishima M
Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention.
Haussler MR; Haussler CA; Bartik L; Whitfield GK; Hsieh JC; Slater S; Jurutka PW
Nutr Rev; 2008 Oct; 66(10 Suppl 2):S98-112. PubMed ID: 18844852
[TBL] [Abstract][Full Text] [Related]
7. Are vitamin D receptor activators useful for the treatment of thrombosis?
Wu-Wong JR
Curr Opin Investig Drugs; 2009 Sep; 10(9):919-27. PubMed ID: 19705334
[TBL] [Abstract][Full Text] [Related]
8. Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential.
Gocek E; Kiełbiński M; Wyłób P; Kutner A; Marcinkowska E
Steroids; 2008 Dec; 73(14):1359-66. PubMed ID: 18644400
[TBL] [Abstract][Full Text] [Related]
9. Identification of the functional vitamin D response elements in the human MDR1 gene.
Saeki M; Kurose K; Tohkin M; Hasegawa R
Biochem Pharmacol; 2008 Aug; 76(4):531-42. PubMed ID: 18602086
[TBL] [Abstract][Full Text] [Related]
10. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.
Raimondi S; Johansson H; Maisonneuve P; Gandini S
Carcinogenesis; 2009 Jul; 30(7):1170-80. PubMed ID: 19403841
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and prevention of breast cancer.
Welsh J
Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver.
Khan AA; Chow EC; van Loenen-Weemaes AM; Porte RJ; Pang KS; Groothuis GM
Eur J Pharm Sci; 2009 May; 37(2):115-25. PubMed ID: 19429418
[TBL] [Abstract][Full Text] [Related]
13. 1Alpha, 25-dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor.
Sun X; Zemel MB
Int J Obes (Lond); 2008 Aug; 32(8):1305-11. PubMed ID: 18427562
[TBL] [Abstract][Full Text] [Related]
14. [VDR knockout mice and bone mineralization disorders].
Takeyama K; Yamamoto Y; Kato S
Clin Calcium; 2007 Oct; 17(10):1560-6. PubMed ID: 17906409
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic and pharmacodynamic studies of a 25-hydroxyvitamin D3 derivative in prostate cancer cells.
Lambert JR; Young CD; Persons KS; Ray R
Biochem Biophys Res Commun; 2007 Sep; 361(1):189-95. PubMed ID: 17658477
[TBL] [Abstract][Full Text] [Related]
16. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D receptor in cancer.
Thorne J; Campbell MJ
Proc Nutr Soc; 2008 May; 67(2):115-27. PubMed ID: 18412986
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
19. A kinetic overview of the receptors involved in 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 signaling: a systems biology approach.
Holmén J; Jansson A; Larsson D
Crit Rev Eukaryot Gene Expr; 2009; 19(3):181-96. PubMed ID: 19883364
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
Ting HJ; Bao BY; Reeder JE; Messing EM; Lee YF
Mol Cancer Res; 2007 Sep; 5(9):967-80. PubMed ID: 17855664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
